Alzheimer Europe’s May 2022 newsletter brings you the latest news on developments in the dementia field, across Europe and beyond.

Summaries of a few of our top stories appear below.

Our monthly newsletter reaches around 12,000 people and we are always happy to receive feedback, or suggestions regarding news items to share.


12 May: Alzheimer Europe co-hosts webinar on Patient involvement in Brain Health and launches call to action

Alzheimer Europe co-organised a webinar with the European Federation of Neurological Alliances (EFNA) and GAMIAN-Europe, on "Patient involvement in Brain Health: Safeguarding the future of Brain Health for patients". A joint Call to Action was also launched, highlighting the need for improved Patient Involvement in brain health research in Europe. Helen Rochford-Brennan was among the speakers, highlighting that people with dementia must be equal partners in research.

13 May: EWGPWD meets face to face for the first time in over two years and re-elects Chairperson

The European Working Group of People with Dementia (EWGPWD) met face-to-face this month, for the first time in over two years. They worked on several projects, within the framework of Public Involvement. At the meeting, Chris Roberts was re-elected as Chairperson, for the next term of office (starting from October). The group also discussed the organisation of its special symposium at the 32nd Alzheimer Europe Conference.



15 May: It has been 20 years since the last approval of an Alzheimer’s medication in Europe

It has been 20 years since the last approval of an Alzheimer’s medicine by the European Medicines' Agency, meaning that people living in Europe affected by Alzheimer’s disease (AD) have been waiting to gain access to better treatments for two decades. With Biogen’s recent withdrawal of its marketing authorisation application for aducanumab, the wait goes on.


15 May: Call for abstracts for the 32nd Alzheimer Europe Conference is closed

The call for abstracts is now closed for the 32nd Alzheimer Europe Conference, which will take place in Bucharest, Romania, under the banner “Building Bridges”. We are pleased to have received almost 270 abstracts, all of which are now being reviewed by the Scientific Committee. All submitting authors will be informed of the Committee's decision in mid-June. 



27 May: World Health Assembly passes neurological conditions action plan

Delegates at the 75th World Health Assembly have approved a new intersectoral global action plan on epilepsy and other neurological disorders (including stroke, migraine, dementia and meningitis) that aims to improve access to care and treatment for people living with these conditions, while preventing new cases and promoting brain health and development across the life course.